Entrada Therapeutics (TRDA) Current Taxes (2023 - 2025)

Entrada Therapeutics' Current Taxes history runs 3 years deep, the most recent figure standing at $620000.0 for Q3 2025.

• In Q3 2025, Current Taxes fell 72.46% year-over-year to $620000.0; the TTM figure through Sep 2025 stood at $620000.0 (down 72.46% YoY), while the FY2024 annual figure was $667000.0, down 83.42% from the prior year.
• Current Taxes was $620000.0 for Q3 2025 at Entrada Therapeutics, down from $802000.0 in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $7.4 million in Q2 2023 to a low of $620000.0 in Q3 2025.
• Historically, Current Taxes has averaged $3.2 million across 3 years, with a median of $3.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Taxes plunged 44.14% in 2024, then slumped 86.3% in 2025.
• A 3-year view of Current Taxes shows it stood at $4.0 million in 2023, then plunged by 83.42% to $667000.0 in 2024, then retreated by 7.05% to $620000.0 in 2025.
• The last three Current Taxes figures came in at $620000.0 (Q3 2025), $802000.0 (Q1 2025), and $667000.0 (Q4 2024), per Business Quant data.